Mindmed appoints dr. robert dworkin to scientific advisory board

New york, aug. 10, 2021 /prnewswire/ -- mindmed (nasdaq: mnmd) (neo: mmed) (de: mmq), a leading biotech company developing psychedelic-inspired therapies, announces the addition of robert h. dworkin, ph.d.
MNMD Ratings Summary
MNMD Quant Ranking